SlideShare a Scribd company logo
1 of 34
PONLAPAT ROJNUCKARIN, M.D. PH.D. CHULALONGKORN UNIVERSITY How do I treat refractory ITP
Time to responses to initial treatments Blood. 2009;113:2386
Definition of Refractory ITP BJH 2008; 143, 16
Conditions to be excluded ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],BJH 2008; 143, 16
May-Hegglin Anomaly
Bernard-Soulier syndrome
Aim of therapy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]
Initial treatment ,[object Object],[object Object],[object Object],[object Object],[object Object]
P=.016 P=.046 Praituan, JTH 2009; 7: 1036
Prednisolone tapering ,[object Object],[object Object],[object Object],[object Object]
 
Splenectomy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Kojouri K et al, Blood 2004
Splenectomy ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Kojouri K et al, Blood 2004
Laparoscopic Splenectomy
Treatment of ITP
Refractory ITP denied splenectomy. ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],McMillan
Pulse Dexamethasone ,[object Object],[object Object],[object Object],[object Object],N Engl J Med 1994 ;330:1560-4
Dapsone ,[object Object],[object Object],[object Object],[object Object],[object Object],Br J Haematol. 1997;97:336-9.
Colchicine ,[object Object],[object Object],[object Object],[object Object],Arch Intern Med. 1984; 144:2198
Danazol ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Ahn YS. Acta Haematol. 1990;84: 122-9 Maloisel F. Am J Med. 2004; 116: 590-4
Rituximab ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Br J Haematol. 2004 Apr;125(2):232-9.
Outcomes of Rituximab Blood. 2008;112:999
Immunosuppressive agents ,[object Object],[object Object],[object Object],[object Object],[object Object],Ann Intern Med. 2004; 140: 112-20
Cyclophosphamide ,[object Object],[object Object],[object Object],[object Object],[object Object]
Azathioprine ,[object Object],[object Object],[object Object],[object Object],*Br J Clin Pharm 2004; 58: 66
Combination chemotherapy ,[object Object],[object Object],[object Object],[object Object],[object Object],N Engl J Med 1993;328:1226-9
Steroid refractory or dependence ITP Alternatives with Low side effect Pulse Dexamethasone Colchicine, Dapsone, Danazol, Rituximab, Combinations  Splenectomy Second line: Cyclophosphamide, Azathioprine, MMF, CSP Third line: Combination chemotherapy, BMT, Experimental Rx
Control of  TPO Levels NEJM 1998; 339: 746
Eltrombopag vs. placebo Lancet 2009; 373: 641
Romiplostim: Long-term response Blood 2009; 113: 2161
Thrombopoietic agents ,[object Object],[object Object],[object Object],[object Object]
Patients with major bleeding ,[object Object],[object Object],[object Object],[object Object]
Massive platelet transfusion (N=10) 3-7 Apheresis units Thromb Haemost 2008; 100: 762
Take home message ,[object Object],[object Object],[object Object]

More Related Content

What's hot

Management of Multiple myeloma
Management of Multiple myelomaManagement of Multiple myeloma
Management of Multiple myeloma
orthoprinciples
 
Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome
Microangiopathic hemolytic Anemia & Hemolytic Uremic SyndromeMicroangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome
Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome
Arya Anish
 

What's hot (20)

Mantle Cell Lymphoma PPT.pptx
Mantle Cell Lymphoma PPT.pptxMantle Cell Lymphoma PPT.pptx
Mantle Cell Lymphoma PPT.pptx
 
Hemophagocytic lymphohistiocytosis
Hemophagocytic lymphohistiocytosisHemophagocytic lymphohistiocytosis
Hemophagocytic lymphohistiocytosis
 
Bone marrow failure syndromes.ppt
Bone marrow failure syndromes.pptBone marrow failure syndromes.ppt
Bone marrow failure syndromes.ppt
 
Intravenous immunoglobulin (IVIG)
Intravenous immunoglobulin (IVIG)Intravenous immunoglobulin (IVIG)
Intravenous immunoglobulin (IVIG)
 
Immunoglobulin therapy
Immunoglobulin therapyImmunoglobulin therapy
Immunoglobulin therapy
 
Myeloproliferative disorders
Myeloproliferative disordersMyeloproliferative disorders
Myeloproliferative disorders
 
ANCA
ANCA ANCA
ANCA
 
CML - DIAGNOSIS,MANAGEMENT AND RECENT ADVANCES
CML - DIAGNOSIS,MANAGEMENT AND RECENT ADVANCESCML - DIAGNOSIS,MANAGEMENT AND RECENT ADVANCES
CML - DIAGNOSIS,MANAGEMENT AND RECENT ADVANCES
 
immunotherapy and PDL1 IHC
immunotherapy and PDL1 IHCimmunotherapy and PDL1 IHC
immunotherapy and PDL1 IHC
 
Tailoring Therapy for Follicular Lymphoma Based on the Latest Evidence
Tailoring Therapy for Follicular Lymphoma Based on the Latest EvidenceTailoring Therapy for Follicular Lymphoma Based on the Latest Evidence
Tailoring Therapy for Follicular Lymphoma Based on the Latest Evidence
 
Myelodysplastic syndrome according to WHO 2016
Myelodysplastic syndrome according to WHO 2016Myelodysplastic syndrome according to WHO 2016
Myelodysplastic syndrome according to WHO 2016
 
Chapter 24.3 metronomic chemotherapy
Chapter 24.3 metronomic chemotherapyChapter 24.3 metronomic chemotherapy
Chapter 24.3 metronomic chemotherapy
 
Thrombophilia
ThrombophiliaThrombophilia
Thrombophilia
 
Multiple myeloma
Multiple myelomaMultiple myeloma
Multiple myeloma
 
chronic myeloid leukemia
chronic myeloid leukemiachronic myeloid leukemia
chronic myeloid leukemia
 
Management of Multiple myeloma
Management of Multiple myelomaManagement of Multiple myeloma
Management of Multiple myeloma
 
Multiple myeloma
Multiple myelomaMultiple myeloma
Multiple myeloma
 
Common variable immunodeficiency 2017
Common variable immunodeficiency 2017Common variable immunodeficiency 2017
Common variable immunodeficiency 2017
 
Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome
Microangiopathic hemolytic Anemia & Hemolytic Uremic SyndromeMicroangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome
Microangiopathic hemolytic Anemia & Hemolytic Uremic Syndrome
 
plasma cell neoplasm
plasma cell neoplasmplasma cell neoplasm
plasma cell neoplasm
 

Viewers also liked

Kevin Ops Resume
Kevin Ops ResumeKevin Ops Resume
Kevin Ops Resume
Kevin Clark
 
UXPSystems_whitepaper_Privacy_Nov182016
UXPSystems_whitepaper_Privacy_Nov182016UXPSystems_whitepaper_Privacy_Nov182016
UXPSystems_whitepaper_Privacy_Nov182016
Andrey Plotnikov
 
The technological properties of refractory
The technological properties of refractory The technological properties of refractory
The technological properties of refractory
Ahmed Abd Elmegeed
 

Viewers also liked (20)

Anode vessel refractory linings
Anode vessel refractory liningsAnode vessel refractory linings
Anode vessel refractory linings
 
MANUAL DE RAPTOR
MANUAL DE RAPTORMANUAL DE RAPTOR
MANUAL DE RAPTOR
 
PESTLE-RUSSIA
PESTLE-RUSSIAPESTLE-RUSSIA
PESTLE-RUSSIA
 
Gestor de proyectos: comprendo cantando: el uso de textos musicales para la c...
Gestor de proyectos: comprendo cantando: el uso de textos musicales para la c...Gestor de proyectos: comprendo cantando: el uso de textos musicales para la c...
Gestor de proyectos: comprendo cantando: el uso de textos musicales para la c...
 
TDC2016SP - Enterprise Apps: Arquiteturas extremas e escaláveis
TDC2016SP - Enterprise Apps: Arquiteturas extremas e escaláveisTDC2016SP - Enterprise Apps: Arquiteturas extremas e escaláveis
TDC2016SP - Enterprise Apps: Arquiteturas extremas e escaláveis
 
Kevin Ops Resume
Kevin Ops ResumeKevin Ops Resume
Kevin Ops Resume
 
Noerr LLP - Sommerakademie
Noerr LLP - SommerakademieNoerr LLP - Sommerakademie
Noerr LLP - Sommerakademie
 
Anno1701
Anno1701Anno1701
Anno1701
 
Toma composición
Toma composiciónToma composición
Toma composición
 
TDC2016SP - Conhecendo o Ecossistema Linkit para Makers
TDC2016SP - Conhecendo o Ecossistema Linkit para MakersTDC2016SP - Conhecendo o Ecossistema Linkit para Makers
TDC2016SP - Conhecendo o Ecossistema Linkit para Makers
 
TDC2016SP - Rockets!
TDC2016SP - Rockets!TDC2016SP - Rockets!
TDC2016SP - Rockets!
 
KR letter
KR letterKR letter
KR letter
 
UXPSystems_whitepaper_Privacy_Nov182016
UXPSystems_whitepaper_Privacy_Nov182016UXPSystems_whitepaper_Privacy_Nov182016
UXPSystems_whitepaper_Privacy_Nov182016
 
Imagenes de nuestra infancia
Imagenes de nuestra infanciaImagenes de nuestra infancia
Imagenes de nuestra infancia
 
TDC SP 2016 - EVDnC - Extreme Value-Driven Coaching - 4 sprints em 5 dias
TDC SP 2016 - EVDnC - Extreme Value-Driven Coaching - 4 sprints em 5 diasTDC SP 2016 - EVDnC - Extreme Value-Driven Coaching - 4 sprints em 5 dias
TDC SP 2016 - EVDnC - Extreme Value-Driven Coaching - 4 sprints em 5 dias
 
Seta Capital - Small Trouble In Big China
Seta Capital - Small Trouble In Big ChinaSeta Capital - Small Trouble In Big China
Seta Capital - Small Trouble In Big China
 
The technological properties of refractory
The technological properties of refractory The technological properties of refractory
The technological properties of refractory
 
Работа с контрагентами. ЭКспорт
Работа с контрагентами. ЭКспортРабота с контрагентами. ЭКспорт
Работа с контрагентами. ЭКспорт
 
TDC Floripa - Trilha iOS - Debate sobre o futuro da plataforma
TDC Floripa - Trilha iOS - Debate sobre o futuro da plataformaTDC Floripa - Trilha iOS - Debate sobre o futuro da plataforma
TDC Floripa - Trilha iOS - Debate sobre o futuro da plataforma
 
TDC2016SP - Trilha Startups
TDC2016SP - Trilha StartupsTDC2016SP - Trilha Startups
TDC2016SP - Trilha Startups
 

Similar to Refractory ITP

Methimazole induced agranulocytosis
Methimazole induced agranulocytosisMethimazole induced agranulocytosis
Methimazole induced agranulocytosis
Choying Chen
 
Renal Transplantation Dr. Jorge L. Posada
Renal Transplantation   Dr. Jorge L. PosadaRenal Transplantation   Dr. Jorge L. Posada
Renal Transplantation Dr. Jorge L. Posada
MedicineAndHealthCancer
 
Systemic corticosteroids in the treatment of acute exacerbations of copd
Systemic corticosteroids in the treatment of acute exacerbations of copdSystemic corticosteroids in the treatment of acute exacerbations of copd
Systemic corticosteroids in the treatment of acute exacerbations of copd
Choying Chen
 
apmlseminarmine
apmlseminarmineapmlseminarmine
apmlseminarmine
icdlab
 
All-trans retinoic acid related complications in a patient with acute promy...
All-trans retinoic acid related  complications in a patient with acute  promy...All-trans retinoic acid related  complications in a patient with acute  promy...
All-trans retinoic acid related complications in a patient with acute promy...
Choying Chen
 
The Impact Of Sedatives On Sleep In The Icu
The Impact Of Sedatives On Sleep In The IcuThe Impact Of Sedatives On Sleep In The Icu
The Impact Of Sedatives On Sleep In The Icu
KyleAmelung
 

Similar to Refractory ITP (20)

Methimazole induced agranulocytosis
Methimazole induced agranulocytosisMethimazole induced agranulocytosis
Methimazole induced agranulocytosis
 
Patophysiology of ACS: Role of Thrombosis
Patophysiology of ACS: Role of ThrombosisPatophysiology of ACS: Role of Thrombosis
Patophysiology of ACS: Role of Thrombosis
 
Renal Transplantation Dr. Jorge L. Posada
Renal Transplantation   Dr. Jorge L. PosadaRenal Transplantation   Dr. Jorge L. Posada
Renal Transplantation Dr. Jorge L. Posada
 
Minimal Change Disease
Minimal Change DiseaseMinimal Change Disease
Minimal Change Disease
 
Myocardial infraction by satyavardhan pharm.d
Myocardial infraction by satyavardhan pharm.dMyocardial infraction by satyavardhan pharm.d
Myocardial infraction by satyavardhan pharm.d
 
TTP HUSについて
TTP HUSについてTTP HUSについて
TTP HUSについて
 
Systemic corticosteroids in the treatment of acute exacerbations of copd
Systemic corticosteroids in the treatment of acute exacerbations of copdSystemic corticosteroids in the treatment of acute exacerbations of copd
Systemic corticosteroids in the treatment of acute exacerbations of copd
 
Tumor lysis syndrome
Tumor lysis syndromeTumor lysis syndrome
Tumor lysis syndrome
 
Immunosuppression immunomodulation
Immunosuppression immunomodulationImmunosuppression immunomodulation
Immunosuppression immunomodulation
 
Chemotherapy for Hodgkins disease
Chemotherapy for Hodgkins diseaseChemotherapy for Hodgkins disease
Chemotherapy for Hodgkins disease
 
apmlseminarmine
apmlseminarmineapmlseminarmine
apmlseminarmine
 
Renal transplant
Renal transplant Renal transplant
Renal transplant
 
All-trans retinoic acid related complications in a patient with acute promy...
All-trans retinoic acid related  complications in a patient with acute  promy...All-trans retinoic acid related  complications in a patient with acute  promy...
All-trans retinoic acid related complications in a patient with acute promy...
 
The Impact Of Sedatives On Sleep In The Icu
The Impact Of Sedatives On Sleep In The IcuThe Impact Of Sedatives On Sleep In The Icu
The Impact Of Sedatives On Sleep In The Icu
 
Chemotherapy in head and neck
Chemotherapy in head and neck Chemotherapy in head and neck
Chemotherapy in head and neck
 
Rsi
RsiRsi
Rsi
 
Relapse.Remitting.MS
Relapse.Remitting.MSRelapse.Remitting.MS
Relapse.Remitting.MS
 
Hypoglycemia & Management of Diabetes in CKD Stage V
Hypoglycemia & Management of Diabetes in CKD Stage VHypoglycemia & Management of Diabetes in CKD Stage V
Hypoglycemia & Management of Diabetes in CKD Stage V
 
Unmet need in multiple myeloma
Unmet need in multiple myelomaUnmet need in multiple myeloma
Unmet need in multiple myeloma
 
Principles of diagnosis & management of acute pulmonary
Principles of diagnosis & management of acute pulmonaryPrinciples of diagnosis & management of acute pulmonary
Principles of diagnosis & management of acute pulmonary
 

More from Artit Ungkanont

Stem Cells And Potential Clinical Applications
Stem Cells And Potential Clinical ApplicationsStem Cells And Potential Clinical Applications
Stem Cells And Potential Clinical Applications
Artit Ungkanont
 

More from Artit Ungkanont (10)

A life of a thalassemia patient 1e
A life of a thalassemia patient 1eA life of a thalassemia patient 1e
A life of a thalassemia patient 1e
 
CIO Roles and Responsibilities
CIO Roles and ResponsibilitiesCIO Roles and Responsibilities
CIO Roles and Responsibilities
 
Transfusion and complications 2011
Transfusion and complications 2011Transfusion and complications 2011
Transfusion and complications 2011
 
Thalassemia
ThalassemiaThalassemia
Thalassemia
 
Aplastic anemia 2011
Aplastic anemia 2011Aplastic anemia 2011
Aplastic anemia 2011
 
Polycythemai vera and Essential Thrombocytosis
Polycythemai vera and Essential ThrombocytosisPolycythemai vera and Essential Thrombocytosis
Polycythemai vera and Essential Thrombocytosis
 
CLL - TSH Midyear 2009
CLL - TSH Midyear 2009CLL - TSH Midyear 2009
CLL - TSH Midyear 2009
 
AIHA
AIHAAIHA
AIHA
 
HL7 for TMI November 2009
HL7 for TMI November 2009HL7 for TMI November 2009
HL7 for TMI November 2009
 
Stem Cells And Potential Clinical Applications
Stem Cells And Potential Clinical ApplicationsStem Cells And Potential Clinical Applications
Stem Cells And Potential Clinical Applications
 

Refractory ITP